355 related articles for article (PubMed ID: 33652579)
81. The use of psychostimulants in cancer patients.
Portela MA; Rubiales AS; Centeno C
Curr Opin Support Palliat Care; 2011 Jun; 5(2):164-8. PubMed ID: 21532350
[TBL] [Abstract][Full Text] [Related]
82. High-Dose Vitamin C: Preclinical Evidence for Tailoring Treatment in Cancer Patients.
Giansanti M; Karimi T; Faraoni I; Graziani G
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33804775
[TBL] [Abstract][Full Text] [Related]
83. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial.
Creagan ET; Moertel CG; O'Fallon JR; Schutt AJ; O'Connell MJ; Rubin J; Frytak S
N Engl J Med; 1979 Sep; 301(13):687-90. PubMed ID: 384241
[TBL] [Abstract][Full Text] [Related]
84. Vitamin C-Sources, Physiological Role, Kinetics, Deficiency, Use, Toxicity, and Determination.
Doseděl M; Jirkovský E; Macáková K; Krčmová LK; Javorská L; Pourová J; Mercolini L; Remião F; Nováková L; Mladěnka P; On Behalf Of The Oemonom
Nutrients; 2021 Feb; 13(2):. PubMed ID: 33668681
[TBL] [Abstract][Full Text] [Related]
85. High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer.
Böttger F; Vallés-Martí A; Cahn L; Jimenez CR
J Exp Clin Cancer Res; 2021 Oct; 40(1):343. PubMed ID: 34717701
[TBL] [Abstract][Full Text] [Related]
86. The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer.
Cameron E; Campbell A
Chem Biol Interact; 1974 Oct; 9(4):285-315. PubMed ID: 4430016
[No Abstract] [Full Text] [Related]
87. Parenteral high‑dose ascorbate - A possible approach for the treatment of glioblastoma (Review).
Renner O; Burkard M; Michels H; Vollbracht C; Sinnberg T; Venturelli S
Int J Oncol; 2021 Jun; 58(6):. PubMed ID: 33955499
[TBL] [Abstract][Full Text] [Related]
88. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison.
Moertel CG; Fleming TR; Creagan ET; Rubin J; O'Connell MJ; Ames MM
N Engl J Med; 1985 Jan; 312(3):137-41. PubMed ID: 3880867
[TBL] [Abstract][Full Text] [Related]
89. Vitamin C in the Treatment of COVID-19.
Milani GP; Macchi M; Guz-Mark A
Nutrients; 2021 Apr; 13(4):. PubMed ID: 33916257
[TBL] [Abstract][Full Text] [Related]
90. Peroxiredoxin 2 oxidation reveals hydrogen peroxide generation within erythrocytes during high-dose vitamin C administration.
Pearson AG; Pullar JM; Cook J; Spencer ES; Vissers MC; Carr AC; Hampton MB
Redox Biol; 2021 Jul; 43():101980. PubMed ID: 33905956
[TBL] [Abstract][Full Text] [Related]
91. High Dose Intravenous Vitamin C for Preventing The Disease Aggravation of Moderate COVID-19 Pneumonia. A Retrospective Propensity Matched Before-After Study.
Zhao B; Liu M; Liu P; Peng Y; Huang J; Li M; Wang Y; Xu L; Sun S; Qi X; Ling Y; Li J; Zhang W; Mao E; Qu J
Front Pharmacol; 2021; 12():638556. PubMed ID: 33967773
[No Abstract] [Full Text] [Related]
92. Vitamin C-Induced Oxalate Nephropathy in a Septic Patient.
Wissanji T; Dupuis ME; Royal V; Pichette V; Wang HT
Crit Care Explor; 2021 Apr; 3(4):e0389. PubMed ID: 33912831
[TBL] [Abstract][Full Text] [Related]
93. Prolongation of survival times of terminal cancer patients by administration of large doses of ascorbate.
Murata A; Morishige F; Yamaguchi H
Int J Vitam Nutr Res Suppl; 1982; 23():103-13. PubMed ID: 6811475
[TBL] [Abstract][Full Text] [Related]
94. Clinical efficacy and safety of oral and intravenous vitamin C use in patients with malignant diseases.
Hoppe C; Freuding M; Büntzel J; Münstedt K; Hübner J
J Cancer Res Clin Oncol; 2021 Oct; 147(10):3025-3042. PubMed ID: 34402972
[TBL] [Abstract][Full Text] [Related]
95. The efficacy of intravenous vitamin C in critically ill patients: A meta-analysis of randomized controlled trials.
Xing X; Xu M; Yang L; Zhang W; Niu X; Gao D
Clin Nutr; 2021 May; 40(5):2630-2639. PubMed ID: 33933729
[TBL] [Abstract][Full Text] [Related]
96. The role of vitamin C in epigenetic cancer therapy.
Mikkelsen SU; Gillberg L; Lykkesfeldt J; Grønbæk K
Free Radic Biol Med; 2021 Jul; 170():179-193. PubMed ID: 33789122
[TBL] [Abstract][Full Text] [Related]
97. Vitamin C sensitizes triple negative breast cancer to PI3K inhibition therapy.
Mustafi S; Camarena V; Qureshi R; Sant DW; Wilkes Z; Bilbao D; Slingerland J; Kesmodel SB; Wang G
Theranostics; 2021; 11(8):3552-3564. PubMed ID: 33664847
[No Abstract] [Full Text] [Related]
98. The effect of vitamin C supplementation on lipid profile of type 2 diabetic patients: a systematic review and meta-analysis of clinical trials.
Tareke AA; Hadgu AA
Diabetol Metab Syndr; 2021 Mar; 13(1):24. PubMed ID: 33653396
[TBL] [Abstract][Full Text] [Related]
99. Effect of six weeks 1000 mg/day vitamin C supplementation and healthy training in elderly women on genes expression associated with the immune response - a randomized controlled trial.
Żychowska M; Grzybkowska A; Zasada M; Piotrowska A; Dworakowska D; Czerwińska-Ledwig O; Pilch W; Antosiewicz J
J Int Soc Sports Nutr; 2021 Mar; 18(1):19. PubMed ID: 33653365
[TBL] [Abstract][Full Text] [Related]
100. Impact of Intravenous Vitamin C Administration in Reducing Severity of Symptoms in Breast Cancer Patients During Treatment.
Mansoor F; Kumar S; Rai P; Anees F; Kaur N; Devi A; Kumar B; Memon MK; Khan S
Cureus; 2021 May; 13(5):e14867. PubMed ID: 34113504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
